Cargando…

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias

Cardiac arrhythmias are a major cause of morbidity and mortality. In younger patients, the majority of sudden cardiac deaths have an underlying Mendelian genetic cause. Over the last 15 years, enormous progress has been made in identifying the distinct clinical phenotypes and in studying the basic c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoekstra, Maaike, Mummery, Christine L., Wilde, Arthur A. M., Bezzina, Connie R., Verkerk, Arie O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2012
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449331/ https://www.ncbi.nlm.nih.gov/pubmed/23015789 http://dx.doi.org/10.3389/fphys.2012.00346

Ejemplares similares

Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia
por: Campostrini, Giulia, et al.
Publicado: (2022)

Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp
por: Verkerk, Arie O., et al.
Publicado: (2017)

Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties
por: van den Brink, Lettine, et al.
Publicado: (2020)

Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual I(K1)
por: Meijer van Putten, Rosalie M. E., et al.
Publicado: (2015)

Switch From Fetal to Adult SCN5A Isoform in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Unmasks the Cellular Phenotype of a Conduction Disease–Causing Mutation
por: Veerman, Christiaan C., et al.
Publicado: (2017)

Aconitine-induced cardiac arrhythmia in human induced pluripotent stem cell-derived cardiomyocytes
por: Zhang, Feng, et al.
Publicado: (2018)

Cardiac Subtype-Specific Modeling of K(v)1.5 Ion Channel Deficiency Using Human Pluripotent Stem Cells
por: Marczenke, Maike, et al.
Publicado: (2017)

Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research
por: Mummery, Christine L.
Publicado: (2018)

Ultrarapid Delayed Rectifier K(+) Channelopathies in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Hilderink, Sarah, et al.
Publicado: (2020)

hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities
por: Veerman, Christiaan C., et al.
Publicado: (2016)

Genetic Basis of Ventricular Arrhythmias
por: Pazoki, Raha, et al.
Publicado: (2010)

Extracellular Vesicles Released by Human Induced-Pluripotent Stem Cell-Derived Cardiomyocytes Promote Angiogenesis
por: Dougherty, Julie A., et al.
Publicado: (2018)

Substrate Stiffness Influences Structural and Functional Remodeling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Körner, Arlene, et al.
Publicado: (2021)

Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations
por: Casini, Simona, et al.
Publicado: (2017)

Beyond Family: Modeling Non-hereditary Heart Diseases With Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Martewicz, Sebastian, et al.
Publicado: (2020)

Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors
por: Carvalho, A. B., et al.
Publicado: (2022)

Human induced pluripotent stem cell-derived cardiomyocytes as an electrophysiological model: Opportunities and challenges—The Hamburg perspective
por: Ismaili, Djemail, et al.
Publicado: (2023)

Optogenetic Hyperpolarization of Cardiomyocytes Terminates Ventricular Arrhythmia
por: Funken, Maximilian, et al.
Publicado: (2019)

Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
por: Feaster, Tromondae K., et al.
Publicado: (2022)

An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes
por: McKeithan, Wesley L., et al.
Publicado: (2017)

Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
por: Giacomelli, E., et al.
Publicado: (2017)

Commentary: Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
por: Bierhuizen, Mark F. A., et al.
Publicado: (2023)

Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells
por: Reisqs, J. B., et al.
Publicado: (2023)

Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease
por: van Meer, Berend J., et al.
Publicado: (2016)

Zebrafish: a novel research tool for cardiac (patho)electrophysiology and ion channel disorders
por: Verkerk, Arie O., et al.
Publicado: (2012)

Identifying Acute Cardiac Hazard in Early Drug Discovery Using a Calcium Transient High-Throughput Assay in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lu, Hua Rong, et al.
Publicado: (2022)

iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
por: Simons, Eline, et al.
Publicado: (2023)

In silico analysis of the contribution of cardiomyocyte-fibroblast electromechanical interaction to the arrhythmia
por: Kursanov, Alexander, et al.
Publicado: (2023)

Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology
por: Devalla, Harsha D, et al.
Publicado: (2015)

Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Park, Misun, et al.
Publicado: (2018)

Platelets and Cardiac Arrhythmia
por: de Jong, Jonas S. S. G., et al.
Publicado: (2010)

Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
por: Sala, Luca, et al.
Publicado: (2016)

Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes
por: Dambrot, Cheryl, et al.
Publicado: (2014)

Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming
por: Sadahiro, Taketaro
Publicado: (2019)

Identification of an I(Na)-dependent and I(to)-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patient
por: Ma, Dongrui, et al.
Publicado: (2018)

The Linkage Phase of the Polymorphism KCNH2-K897T Influences the Electrophysiological Phenotype in hiPSC Models of LQT2
por: van den Brink, Lettine, et al.
Publicado: (2021)

Challenges for the Therapeutic use of Pluripotent Stem Derived Cells
por: Forsberg, Magda, et al.
Publicado: (2012)

Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells
por: Giacomelli, Elisa, et al.
Publicado: (2017)

A computational model of induced pluripotent stem‐cell derived cardiomyocytes incorporating experimental variability from multiple data sources
por: Kernik, Divya C., et al.
Publicado: (2019)

Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)
por: Sala, Luca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6h1l6960jiedb3145oqoh8cg4k